Flupirtine Determination in Human Blood Plasma by HPLC with Mass-Spectrometric Detection and its Application to Pharmacokinetic Studies


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

A validated method for quantitative determination of flupirtine in human blood plasma using liquid chromatography combined with tandem mass spectrometry (HPLC-MS/MS) was proposed. Biological samples were prepared by precipitating proteins using MeOH. The chromatographic separation used a Zorbax Eclipse Plus C18 column with gradient elution. A Shimadzu 8040 triple quadrupole mass spectrometer in multiple-reaction-monitoring mode (+MRM) with chemical ionization at atmospheric pressure (APCI) was used to determine the molecular ion of flupirtine with m/z 305.2. Acalibration curve for flupirtine was linear (R = 0.994) in the concentration range 25 – 2,500 ng/mL with a lower detection limit of 25 ng/mL. Validation of the method indicated that it was highly sensitive, specific, accurate, and precise and that the analyte was stable. The method was successfully applied to comparative pharmacokinetic studies of drugs containing flupirtine.

作者简介

L. Krasnykh

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation

编辑信件的主要联系方式.
Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051

T. Rodina

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation

Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051

E. Mel’nikov

I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Trubetskaya St., Moscow, 119991

G. Vasilenko

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation

Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051

V. Smirnov

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991

A. Sokolov

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991

V. Arkhipov

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991

补充文件

附件文件
动作
1. JATS XML

版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2018